908 Devices Inc. (NASDAQ:MASS) CFO Joseph H. Iv Griffith Sells 6,940 Shares

908 Devices Inc. (NASDAQ:MASS) CFO Joseph H. Iv Griffith sold 6,940 shares of the stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $7.08, for a total value of $49,135.20. Following the sale, the chief financial officer now owns 102,930 shares of the company’s stock, valued at approximately $728,744.40. The trade was a 6.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

908 Devices Trading Up 3.9%

Shares of MASS stock opened at $6.94 on Friday. The stock has a 50 day moving average of $5.03 and a two-hundred day moving average of $3.53. 908 Devices Inc. has a 12 month low of $1.81 and a 12 month high of $7.32. The company has a market capitalization of $248.88 million, a P/E ratio of -3.92 and a beta of 0.29.

908 Devices (NASDAQ:MASS) last announced its quarterly earnings data on Tuesday, May 13th. The company reported ($0.22) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.05. 908 Devices had a negative return on equity of 24.60% and a negative net margin of 109.11%. The company had revenue of $11.78 million during the quarter, compared to the consensus estimate of $11.90 million. Sell-side analysts predict that 908 Devices Inc. will post -1.99 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of 908 Devices in a research note on Saturday, May 24th. Two analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $5.33.

Institutional Trading of 908 Devices

A number of hedge funds have recently modified their holdings of MASS. AWM Investment Company Inc. lifted its position in shares of 908 Devices by 210.6% in the 1st quarter. AWM Investment Company Inc. now owns 5,199,924 shares of the company’s stock worth $23,296,000 after acquiring an additional 3,526,000 shares during the period. First Light Asset Management LLC bought a new position in shares of 908 Devices during the 1st quarter worth approximately $7,621,000. Invesco Ltd. bought a new position in shares of 908 Devices during the 1st quarter worth approximately $2,910,000. Essex Investment Management Co. LLC bought a new position in shares of 908 Devices during the 1st quarter worth approximately $2,153,000. Finally, Prescott Group Capital Management L.L.C. bought a new position in shares of 908 Devices during the 4th quarter worth approximately $330,000. Institutional investors own 88.06% of the company’s stock.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.